Press Releases 2012

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System - Oct 10, 2012

Boston Scientific (NYSE: BSX) has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus™ Valve System in up to 120 patients with severe...

Read more

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial - May 15, 2012

Boston Scientific Corporation (NYSE: BSX) announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus™ Aortic Valve System in patients with...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile